Defiance Daily Target 2X Long NVO ETF (NVOX)

NYSEARCA: NVOX · Real-Time Price · USD
10.27
-0.11 (-1.06%)
Feb 27, 2026, 4:00 PM EST - Market closed
-1.06%
Assets $37.08M
Expense Ratio 1.30%
PE Ratio n/a
Shares Out 3.61M
Dividend (ttm) n/a
Dividend Yield n/a
Ex-Dividend Date n/a
Payout Ratio n/a
1-Year Return -89.38%
Volume 1,333,547
Open 10.35
Previous Close 10.38
Day's Range 10.21 - 10.50
52-Week Low 10.21
52-Week High 100.40
Beta n/a
Holdings 12
Inception Date Dec 2, 2024

About NVOX

Fund Home Page

The Defiance Daily Target 2X Long NVO ETF (NVOX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to deliver 2x leveraged exposure to the daily share price movement of NOVO Nordisk A/S - ADR (NVO), less fees and expenses, through derivatives like swap agreements. NVOX was launched on Dec 2, 2024 and is issued by Defiance.

Asset Class Equity
Category Trading--Leveraged Equity
Stock Exchange NYSEARCA
Ticker Symbol NVOX
ETF Provider Defiance

Top 10 Holdings

312.48% of assets
Name Symbol Weight
NOVO-NORDISK SWAP MS n/a 59.76%
US DOLLARS n/a 49.71%
OTHER ASSETS AND LIABILITIES n/a 44.64%
NOVO-NORDISK SWAP NBC-L n/a 32.64%
NOVO-NORDISK SWAP CLEARSTREET n/a 22.66%
NOVO-NORDISK INC SWAP CANTOR n/a 22.14%
NOVO-NORDISK SWAP MAREX n/a 22.10%
NOVO-NORDISK SWAP BMO-L n/a 22.10%
NOVO-NORDISK A/S-SPONS ADR NOMURA n/a 21.59%
United States Treasury Bills 0% B.0 03.19.26 15.15%
View More Holdings

News

Defiance Launches NVOX, the First 2X Leveraged Single-Stock ETF on Novo Nordisk

MIAMI, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Defiance ETFs today launched NVOX, the world's first single-stock leveraged ETF for the pharmaceutical stock Novo Nordisk (NYSE: NVO). As the weight loss marke...

Other symbols: NVO
1 year ago - GlobeNewsWire